Case number 1:23-cv-01079
Orphalan SA v. Novitium Pharma LLC > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Dec 1, 2023 | 7 | NOTICE of Voluntary Dismissal by Orphalan SA as to Defendant Novitium Pharma LLC (Silver, Daniel) (Entered: 12/01/2023) (1) |
| Dec 1, 2023 | N/A | CASE CLOSED (ntl) (Entered: 12/01/2023) (0) |
| Dec 1, 2023 | 8 | Report to the Commissioner of Patents and Trademarks. (ntl) (Entered: 12/01/2023) (2) |
| Oct 4, 2023 | N/A | Case Assigned to Judge Gregory B. Williams. Please include the initials of the Judge (GBW) after the case number on all documents filed. (rjb) (Entered: 10/04/2023) (0) |
| Oct 3, 2023 | 6 | AMENDED DOCUMENT by Orphalan SA. Amendment to 5 Disclosure Statement Corrected. (Joyce, Alexandra) (Entered: 10/03/2023) (1) |
| Sep 29, 2023 | 1 | Complaint* (1) |
| Sep 29, 2023 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (apk) (Entered: 09/29/2023) (3) |
| Sep 29, 2023 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 8/21/2023. Date of Expiration of Patent: 5/3/2039.Thirty Month Stay Deadline: 4/28/2029. (apk) (Entered: 09/29/2023) (2) |
| Sep 29, 2023 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,988,436 ;11,072,577. (apk) (Entered: 09/29/2023) (1) |
| Sep 29, 2023 | 5 | Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Orphalan SA. (apk) (Entered: 09/29/2023) (1) |
| Sep 29, 2023 | N/A | No Summons Issued. (apk) (Entered: 09/29/2023) (0) |
